학술논문
Venetoclax plus cytarabine and azacitidine in relapsed/refractory AML: An open-label, single-arm, phase 2 study
Document Type
Article
Author
Source
In: European Journal of Cancer . (European Journal of Cancer, May 2024, 202)
Subject
Language
English
ISSN
18790852
09598049
09598049